152 related articles for article (PubMed ID: 19403933)
1. Extensive-stage small-cell lung cancer--moving beyond response rate?
Ferraldeschi R; Lorigan P
Ann Oncol; 2009 May; 20(5):801-2. PubMed ID: 19403933
[No Abstract] [Full Text] [Related]
2. Association between incremental gains in the objective response rate and survival improvement in phase III trials of first-line chemotherapy for extensive disease small-cell lung cancer.
Hotta K; Kiura K; Fujiwara Y; Takigawa N; Oze I; Ochi N; Tabata M; Tanimoto M
Ann Oncol; 2009 May; 20(5):829-34. PubMed ID: 19221150
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide in small cell lung cancer: wrong drug or wrong disease?
Rüegg C; Peters S
J Natl Cancer Inst; 2009 Aug; 101(15):1034-5. PubMed ID: 19608998
[No Abstract] [Full Text] [Related]
4. Omitting elective nodal irradiation and irradiating postinduction versus preinduction chemotherapy tumor extent for limited-stage small cell lung cancer: interim analysis of a prospective randomized noninferiority trial.
Hu X; Bao Y; Zhang L; Guo Y; Chen YY; Li KX; Wang WH; Liu Y; He H; Chen M
Cancer; 2012 Jan; 118(1):278-87. PubMed ID: 21598237
[TBL] [Abstract][Full Text] [Related]
5. Mediastinal radiotherapy after multidrug chemotherapy and prophylactic cranial irradiation in patients with SCLC--treatment results after long-term follow-up and literature overview.
Herrmann MK; Bloch E; Overbeck T; Koerber W; Wolff HA; Hille A; Vorwerk H; Hess CF; Muller M; Christiansen H; Pradier O
Cancer Radiother; 2011 Apr; 15(2):81-8. PubMed ID: 20708424
[TBL] [Abstract][Full Text] [Related]
6. Emerging drugs for small-cell lung cancer.
Metro G; Cappuzzo F
Expert Opin Emerg Drugs; 2009 Dec; 14(4):591-606. PubMed ID: 19694501
[TBL] [Abstract][Full Text] [Related]
7. Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer.
Halvorsen TO; Sundstrøm S; Fløtten Ø; Brustugun OT; Brunsvig P; Aasebø U; Bremnes RM; Kaasa S; Grønberg BH
Acta Oncol; 2016 Nov; 55(11):1349-1354. PubMed ID: 27549509
[TBL] [Abstract][Full Text] [Related]
8. An updated meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer.
Shao N; Jin S; Zhu W
J Thorac Oncol; 2012 Feb; 7(2):470-2. PubMed ID: 22252565
[No Abstract] [Full Text] [Related]
9. Thoracic Radiation Therapy in Extensive Disease Small Cell Lung Cancer.
Jeremić B
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):7-9. PubMed ID: 26279017
[No Abstract] [Full Text] [Related]
10. Re: 'A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small-cell lung cancer: a randomized trial'.
Bregni M; Pedrazzoli P
J Natl Cancer Inst; 2009 Jan; 101(1):67; author reply 67-8. PubMed ID: 19116385
[No Abstract] [Full Text] [Related]
11. Re: Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial.
Musallam KM; Taher AT
J Natl Cancer Inst; 2009 Dec; 101(23):1657; author reply 1657-8. PubMed ID: 19858426
[No Abstract] [Full Text] [Related]
12. Thirty years of prophylactic cranial irradiation in patients with small cell lung cancer: a meta-analysis of randomized clinical trials.
Viani GA; Boin AC; Ikeda VY; Vianna BS; Silva RS; Santanella F
J Bras Pneumol; 2012; 38(3):372-81. PubMed ID: 22782608
[TBL] [Abstract][Full Text] [Related]
13. Pravastatin has no advantage in small-cell lung cancer.
Brower V
Lancet Oncol; 2017 Apr; 18(4):e204. PubMed ID: 28285843
[No Abstract] [Full Text] [Related]
14. Guideline for the Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-line Chemotherapy.
Sun A; Durocher-Allen LD; Ellis PM; Ung YC; Goffin JR; Ramchandar K; Darling G
Clin Oncol (R Coll Radiol); 2018 Oct; 30(10):658-666. PubMed ID: 30007803
[TBL] [Abstract][Full Text] [Related]
15. Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).
Salama JK; Gu L; Wang X; Pang HH; Bogart JA; Crawford J; Schild SE; Vokes EE; Ready NE
J Thorac Oncol; 2016 Mar; 11(3):361-9. PubMed ID: 26723241
[TBL] [Abstract][Full Text] [Related]
16. Concurrent versus sequential chemotherapy and radiotherapy in limited disease small cell lung cancer: a retrospective comparative study.
El Sharouni SY; Kal HB; Barten-Van Rijbroek A; Struikmans H; Battermann JJ; Schramel FM
Anticancer Res; 2009 Dec; 29(12):5219-24. PubMed ID: 20044639
[TBL] [Abstract][Full Text] [Related]
17. Impact of the Radiation Dose on Survival after Radiochemotherapy for Small-cell Lung Cancer.
Käsmann L; Janssen S; Schild SE; Rades D
Anticancer Res; 2016 Mar; 36(3):1089-91. PubMed ID: 26977003
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy in small-cell lung cancer: lessons learned and future directions.
Slotman BJ; Senan S
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):998-1003. PubMed ID: 21353159
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of chemotherapy combined hyperfractionated accelerated radiotherapy on limited small cell lung cancer].
Hu X; Bao Y; Chen YY; Gao JM; Wang WH; Liu Y; He H; Sun ZW; Poudel S; Wang Y; Zhuang TT; Zhang L; Chen M
Ai Zheng; 2008 Oct; 27(10):1088-93. PubMed ID: 18851790
[TBL] [Abstract][Full Text] [Related]
20. Phase I dose escalation trial of hypofractionated limited-field external beam thoracic radiotherapy for limited-stage small cell carcinoma of the lung.
Yee D; Hanson J; Butts C; Reiman A; Joy A; Smylie M; Fenton D; Chu Q; Roa W
Radiother Oncol; 2010 Jul; 96(1):78-83. PubMed ID: 20542346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
